Freeslate announces the launch of Core Module automation system

NewsGuard 100/100 Score

Today, Freeslate, Inc. announced the launch of its third generation Core Module automation system (CM3); designed to optimize workflow integration, it enables scientists to leverage a single automated platform to run a diverse array of laboratory applications. The CM3, the latest product from Freeslate, gives scientists a configurable system for preparing, processing and testing intricate samples including biologic formulations, biomass samples, and other complex mixtures.

“The CM3 will streamline how applications are run in today’s labs, ultimately optimizing efficiency, reducing overall R&D costs and accelerating scientific discovery for researchers.”

“We’re excited to debut our latest product offering to the chemical community at the American Chemical Society's Spring 2010 meeting,” said John Senaldi, chief executive officer of Freeslate. “The CM3 will streamline how applications are run in today’s labs, ultimately optimizing efficiency, reducing overall R&D costs and accelerating scientific discovery for researchers.”

The CM3 unites two earlier Freeslate offerings, the Powdernium MtM and the second generation Core Module platform into a single, modular product that can be easily applied to existing lab applications. The new platform offers an extensive list of new features such as a larger deck, an automated tool changer, off-deck access with robotic arms, and a balance and imaging module that accommodates vials, bottles, jars, and plates.

The CM3 is available immediately and is being showcased at the 2010 Spring ACS meeting and exposition at booth #223 in San Francisco, California, March 21 - 25.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ultima announces UG 100™ and reveals disruptive cost and accuracy profile to enable the era of the $100 genome and beyond